Academic literature on the topic 'Antiobesity effects'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antiobesity effects.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Antiobesity effects"
Mark, Allyn L. "Cardiovascular Side Effects of Antiobesity Drugs." Circulation 120, no. 9 (September 2009): 719–21. http://dx.doi.org/10.1161/circulationaha.109.888529.
Full textShiffman, Melvin A. "Anesthesia Risks in Patients Who Have Had Antiobesity Medication." American Journal of Cosmetic Surgery 15, no. 1 (March 1998): 3–5. http://dx.doi.org/10.1177/074880689801500102.
Full textFernández-Galilea, Marta, Pedro L. Prieto-Hontoria, J. Alfredo Martínez, and María J. Moreno-Aliaga. "Antiobesity effects of α-lipoic acid supplementation." Clinical Lipidology 8, no. 3 (June 2013): 371–83. http://dx.doi.org/10.2217/clp.13.19.
Full textHwang, Jin Taek, Sanghee Kim, Bo-ra Yoon, Inwook Choi, and Sang Yoon Choi. "Inhibitory Effects of 4-(4-Methylbenzamino)benzoate on Adipocyte Differentiation." Journal of Chemistry 2015 (2015): 1–4. http://dx.doi.org/10.1155/2015/171570.
Full textCheng, Lizeng, Yang Wei, Lurong Xu, Lanlan Peng, Yuanfeng Wang, and Xinlin Wei. "Gut Microbiota Differentially Mediated by Qingmao Tea and Qingzhuan Tea Alleviated High-Fat-Induced Obesity and Associated Metabolic Disorders: The Impact of Microbial Fermentation." Foods 11, no. 20 (October 14, 2022): 3210. http://dx.doi.org/10.3390/foods11203210.
Full textDebellis, Lindsay R., and Mark J. Wrobel. "Pharmacotherapeutic Options for the Treatment of Patients with Obesity." Journal of Pharmacy Technology 28, no. 5 (September 2012): 211–18. http://dx.doi.org/10.1177/875512251202800508.
Full textAntunes, Kátia Avila, Débora da Silva Baldivia, Paola dos Santos da Rocha, Junior Cesar Casagrande, Eliana Janet Sanjinez Argandoña, Maria do Carmo Vieira, Cláudia Andrea Lima Cardoso, Edson Lucas dos Santos, and Kely de Picoli Souza. "Antiobesity Effects of Hydroethanolic Extract of Jacaranda decurrens Leaves." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–8. http://dx.doi.org/10.1155/2016/4353604.
Full textWilson, Carol. "CB1R inverse agonists—antiobesity effects without the neuropsychiatric adverse effects?" Nature Reviews Endocrinology 8, no. 10 (August 14, 2012): 564. http://dx.doi.org/10.1038/nrendo.2012.145.
Full textChuah, Li Oon, Wan Yong Ho, Boon Kee Beh, and Swee Keong Yeap. "Updates on Antiobesity Effect ofGarciniaOrigin (−)-HCA." Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–17. http://dx.doi.org/10.1155/2013/751658.
Full textIto, Makoto, Sumiaki Fukuda, Shohei Sakata, Hisayo Morinaga, and Takeshi Ohta. "Pharmacological Effects of JTT-551, a Novel Protein Tyrosine Phosphatase 1B Inhibitor, in Diet-Induced Obesity Mice." Journal of Diabetes Research 2014 (2014): 1–7. http://dx.doi.org/10.1155/2014/680348.
Full textDissertations / Theses on the topic "Antiobesity effects"
Ting, Yu-Hsiang, and 丁于翔. "Combination of Lactobacillus with senna extract for antiobesity effects." Thesis, 2016. http://ndltd.ncl.edu.tw/handle/8awf7c.
Full textLee, Hsin-Yi, and 李欣怡. "Antiobesity effects and molecular mechanisms of Hsian-tsao extracts in high-fat diet-induced obese rats." Thesis, 2016. http://ndltd.ncl.edu.tw/handle/j55pvp.
Full text中山醫學大學
營養學研究所
104
Among the world’s population, the prevalence of obesity has been steadily increasing. Obesity is linked to numerous chronic diseases, such as cardiovascular diseases, type 2 diabetes mellitus, and cancers. Hsian-tsao has been reported to exhibit various beneficial biological activities such as antioxidant, anti-inflammatory, hepatoprotective, and renal protective activities. This study aimed to investigate the anti-obesity effects of 0-100% ethanol extracts of Hsian-tsao (0-100EEHT) in vitro and in vivo models. There are two topics included in this study: (1) Composition analyses and in vitro antiobesity effects of Hsian-tsao and 0-100EEHT. (2) Anti-obesity effect of 40EEHT on high-fat diet (HFD)-induced obese rats was also investigated. (1) The result indicated that the crude fiber and nitrogen free extract were the major proximate composition of Hsian-tsao. Total polyphenolics content, antioxidant activity, and the content of phenolic acids (including protocatechuic acid, chlorogenic acid, p-hydroxybenzoic acid, caffeic acid, vanillic acid, p-coumaric acid) in 40EEHT were higher than that of the other EEHTs. The result indicated that 40EEHT significantly decreases the cell number and intracellular triglyceride content in 3T3-L1 adipocytes. (2) In animal model, the result showed that the weights of body, liver, adipose tissues, as well as hepatic total lipid, triglyceride, and cholesterol in 40EEHT group are significantly decreased as compared to the HFD group. Fecal total lipid, triglyceride, and cholesterol in 40EEHT group were significantly increased as compared to those in the HFD group. Furthermore, the serum levels of triglyceride, ketone body, and MDA, and hepatic MDA in 40EEHT group were significantly decreased as compared to those in the HFD group. Moreover, 40EEHT also significantly increased the levels of hepatic trolox equivalent antioxidant capacity (TEAC) and antioxidant enzymes (including GST and GPx) as compared to the HFD group. In histological analyses of liver and adipose tissue, 40EEHT could reduce the lipid accumulation and adipocyte size as compared to the HFD group. In gene expressions, supplementation with 40EEHT upregulated the gene expressions of SIRT1, AMPK, PGC-1α, PGC-1βCPT-1, ACO, UCP-1, ATGL, HSL, and Adiponectin in the perirenal adipose tissues of HFD rats, whereas it downregulated PPAR-r SREBP-1c, ACC, FAS, aP2, FATP1, CD36, and TNF-α. In gene expressions of livers, 40EEHT significantly increased the gene expressions of SIRT1, AMPK, PGC-1α, PGC-1β,PPAR-α,CPT-1, ACO, ATGL, and HSL in the liver of HFD rats, but downregulated ACC, FAS, SCD-1, FATP1, and LPL. The data indicated that the active compounds of chlorogenic acid, p-hydroxybenzoic acid, and caffeic acid from EEHT significantly decrease the intracellular triglyceride content in 3T3-L1 adipocytes. The results demonstrated that the amelioration of 40EEHT on high-fat diet-induced obesity rats might be related to the active compound (caffeic acid). Therefore, 40% ethanol extracts of Hsian-tsao can be developed as a potential nutraceutical ingredient for preventing obesity.
Chou, Pei-Hsuan, and 周佩萱. "Antiobesity effects and molecular mechanisms of quercetin-rich supplement on high-fat diet-induced obese rats." Thesis, 2014. http://ndltd.ncl.edu.tw/handle/18213090271577386004.
Full text中山醫學大學
營養學研究所
102
Obesity has been recognized as a serious public health problem, associated with several health risks. Quercetin, lycopene, taurine, or litchi flower extract have been reported strong potential anti-obesity activity. However, functional formulas exhibits the strongest synergistic effect compared to single supplement. In the present study, the anti-obesity effects of quercetin-rich supplement, which were combined with quercetin, lycopene, taurine, and litchi flower extract, on high-fat diet (HFD)-induced obese rats were investigated. The data indicated that the weights of body, adipose tissues, and liver, and hepatic total lipid, triglyceride, and cholesterol in quercetin-rich supplement groups were significantly decreased as compared with the HFD group. Fecal total lipid, triglyceride, and cholesterol in quercetin-rich supplement groups were significantly increased as compared with the HFD group. In histological analysis of liver and adipose tissue, quercetin-rich supplement groups were significantly decreased in lipid accumulation and adipocyte size as compared with the HFD group. However, quercetin-rich supplement groups were significantly decreased serum malondialdehyde (MDA), and increased the levels of serum trolox equivalent antioxidant capacity (TEAC) and hepatic antioxidant enzymes as compared with the HFD group. In gene expressions of perirenal adipose tissue, quercetin-rich supplement groups were increased the gene expressions of SIRT1, PPAR-γ, ACO, and CPT-1, as well as decreased the gene expressions of PPAR-α, SREBP-1c, ACC, FAS, HMG-CoA reductase, aP2, FATP1, LPL, PAI-1, and TNF-α as compared with the HFD group. In gene expressions of liver, quercetin-rich supplement groups were also decreased the gene expression of HMG-CoA reductase and increased the gene expressions of AMPK, PPAR-α, ACO, ATGL, and HSL as compared with the HFD group. These results demonstrate that intake of quercetin-rich supplement can be developed as a potential nutraceutical ingredient for preventing obesity.
Kung, Chao-pin, and 孔昭蘋. "The effects of conjugated linoleic acid on the antiobesity and antioxidant systems in mice fed with high-fat diet." Thesis, 2012. http://ndltd.ncl.edu.tw/handle/333gc4.
Full text嘉南藥理科技大學
保健營養系
100
Conjugated linoleic acid (CLA) refers to a group of positional and geometric isomers of the omega-6 essential fatty acid, linoleic acid. The reduction effect of CLA on the adipose tissue and body weight in mice has been noticed and widely studied. In our previous study, CLA also increased vitamin E status in mice fed with low-fat diet. The aim of this study was to investigate the effects of conjugated linoleic acid on the antiobesity and antioxidants systems in mice fed with high-fat diet. Twenty-four seven-week-old male C57BL/6J mice were assigned to three groups: LF group (containing 5% soybean oil), HF group (containing 3% soybean oil of +17% lard), and CLA group (containing 2% soybean oil +1% CLA +17% lard) were fed with experimental diets for 8 wk. The results showed that α-tocopherol levels of plasma and liver were significantly highest in CLA group. The TBARS concentration of kidney in CLA group was significantly lower than that in LF group (P < 0.05). The TBARS concentration of lung in CLA group was significantly lower than that in HF group (P < 0.05). The levels of urine 8-isoprostane significantly increased in CLA fed mice. CLA group showed a reduction of COX-2 protein expression in liver. In addition, the activities of CAT, SOD, GPx of liver in CLA group showed significantly lower than that in the other two groups (P <0.05). The concentration of plasma adiponectin was significantly lower in CLA group than that in the other two groups. In CLA group, the cholesterol levels in plasma and the triglyceride levels in liver both showed significantly higher than the other groups. In conclusion, CLA could reduced the retroperitoneal fat and epididymal fat mice fed with high-fat diet. CLA increased the α-tocopherol content in plasma and liver and decreased plasma adiponectin levels. The changes of vitamin E status and antioxidant enzyme activity by CLA were also observed in mice when fed with high-fat diet. However, this could be due to the reduction of body fat (where the vitamin E stored) and the oxidative stress increased by high dietary fat.
Books on the topic "Antiobesity effects"
Carlton, Janis. Effects of the appetite suppressant drug d-fenfluramine in lean and obese female rats: Central and peripheral antiobesity actions. 1987.
Find full textBook chapters on the topic "Antiobesity effects"
Kong, Chang-Suk, and Se-Kwon Kim. "Antiobesity and Antidiabetic Effects of Seaweeds." In Handbook of Marine Macroalgae, 371–77. Chichester, UK: John Wiley & Sons, Ltd, 2011. http://dx.doi.org/10.1002/9781119977087.ch20.
Full textMun, Eun-Gyung, and Youn-Soo Cha. "Korean Traditional Fermented Foods (KTFFs): Antiobesity Effects and Salt Paradox." In ACS Symposium Series, 121–34. Washington, DC: American Chemical Society, 2019. http://dx.doi.org/10.1021/bk-2019-1303.ch009.
Full textCheon, Hyae Gyeong. "Antiobesity Effects of Melanin-Concentrating Hormone Receptor 1 (MCH-R1) Antagonists." In Handbook of Experimental Pharmacology, 383–403. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-24716-3_18.
Full textMaeda, Hayato, Masashi Hosokawa, Tokutake Sashima, and Kazuo Miyashita. "Antiobesity Effect of Fucoxanthin from Edible Seaweeds and Its Multibiological Functions." In ACS Symposium Series, 376–88. Washington, DC: American Chemical Society, 2008. http://dx.doi.org/10.1021/bk-2008-0993.ch032.
Full textWoon, Esther C. Y., and Joel D. W. Toh. "Antiobesity Effects of Natural Products from an Epigenetic Perspective." In Studies in Natural Products Chemistry, 161–93. Elsevier, 2014. http://dx.doi.org/10.1016/b978-0-444-63294-4.00006-1.
Full text"- Antiobesity Effects of Conjugated Linoleic Acid: Fact or Fiction?" In Obesity, 582–603. CRC Press, 2012. http://dx.doi.org/10.1201/b12261-35.
Full textJu, Kim Hyun, and Han Eung-Soo. "Health Promoting Effects of Kimchi." In Advances in Environmental Engineering and Green Technologies, 73–98. IGI Global, 2017. http://dx.doi.org/10.4018/978-1-5225-0591-4.ch004.
Full textJu, Kim Hyun, and Han Eung-Soo. "Health Promoting Effects of Kimchi." In Food Science and Nutrition, 427–51. IGI Global, 2018. http://dx.doi.org/10.4018/978-1-5225-5207-9.ch018.
Full textHase, Tadashi, and Hiroshige Itakura. "Antiobesity Effect of Long-Term Consumption of Dietary Diacylglycerol in Experimental Animal Models." In Diacylglycerol Oil. AOCS Publishing, 2004. http://dx.doi.org/10.1201/9781439822333.ch9.
Full text